在肝切除之前对门静脉栓塞的审查
Ishwarya Sivakumar1, Robert P Liddell2
1Johns Hopkins University School of Medicine, Baltimore, USA.
Journal of surgical oncology
|October 15, 2024
概括
门静脉栓塞是一种新辅助疗法,用于在切除肝脏之前增加未来的肝脏残留物大小. 这种方法旨在预防肝切除术后的肝衰竭,肝切除术后死亡的主要原因.
科学领域:
- 肝胆道手术是肝胆道的手术.
- 手术瘤学手术瘤学
- 胃肠病学 胃肠病学
背景情况:
- 全球肝癌发病率正在上升.
- 切除肝脏和移植为肝癌提供了最长的生存期.
- 肝切除术后肝衰竭 (PHLF) 是肝切除后死亡的重要原因.
研究的目的:
- 审查门静脉栓塞 (PVE) 作为一种新辅助疗法.
- 解释PVE如何诱导未来肝残存 (FLR) 的过度缩小.
- 讨论PVE在预防PHLF中的作用.
主要方法:
- 审查关于PVE的现有文献.
- 对PVE诱导FLR缩的机制的分析.
- 讨论PVE的临床结果和适应症.
主要成果:
- PVE有效地增加了FLR的体积.
- 增加FLR体积与减少PHLF发病率有关.
- 在切除肝脏之前,PVE是小FLR患者的宝贵策略.
结论:
- 门静脉栓塞是肝癌患者接受切除的关键新辅助治疗方法.
- PVE可以减轻肝衰竭和PHLF的风险.
- 这种技术增强了手术的候选性,并改善了肝癌手术的结果.
相关概念视频
Esophageal Varices-II: Clinical Features and Management
47
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
47
Venous Thrombosis III: Interprofessional Care
3
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
3


